Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
236.71B
Market cap236.71B
Price-Earnings ratio
26.35
Price-Earnings ratio26.35
Dividend yield
2.59%
Dividend yield2.59%
Average volume
3.22M
Average volume3.22M
High today
$409.79
High today$409.79
Low today
$401.07
Low today$401.07
Open price
$404.41
Open price$404.41
Volume
726.94K
Volume726.94K
52 Week high
$418.40
52 Week high$418.40
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

The current Amgen(AMGN) stock price is $409.75, with a market capitalization of 236.71B. The stock trades at a price-to-earnings (P/E) ratio of 26.35 and offers a dividend yield of 2.59%.

On 2026-08-07, Amgen(AMGN) stock traded between a low of $401.07 and a high of $409.79. Shares are currently priced at $409.75, which is +2.2% above the low and -0.0% below the high.

The Amgen(AMGN)'s current trading volume is 726.94K, compared to an average daily volume of 3.22M.

During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $418.40 at its peak.

During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $418.40 at its peak.

AMGN News

CNBC 2h
Trade Tracker: Kevin Simpson buys more Amgen - CNBC

...

Trade Tracker: Kevin Simpson buys more Amgen - CNBC
TipRanks 9h
Amgen price target raised to $405 from $345 at Citi

Citi raised the firm’s price target on Amgen (AMGN) to $405 from $345 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q2...

Nasdaq 1d
Upcoming Dividend Run For AMGN?

This morning a "Potential Dividend Run Alert" went out for Amgen Inc (NASD: AMGN), at our DividendChannel.com Dividend Alerts service (a free email alerts featu...

Upcoming Dividend Run For AMGN?

Analyst ratings

49%

of 35 ratings
Buy
40%
Hold
48.6%
Sell
11.4%

More AMGN News

Simply Wall St 2d
Amgen Could Be 8% Overvalued Following Raised 2026 Guidance

Amgen (AMGN) stock is back in focus after the company beat Wall Street expectations in its second quarter 2026 report and raised full year revenue and earnings...

Amgen Could Be 8% Overvalued Following Raised 2026 Guidance
Nasdaq 3d
Amgen Q2 Earnings Call Highlights

Amgen (NASDAQ:AMGN) reported second-quarter revenue above $10 billion, up 10% from a year earlier, as growth across several key medicines offset competitive pre...

Amgen Q2 Earnings Call Highlights
The Wall Street Journal 3d
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

Amgen said it was halting the development of AMG 513, a potential obesity treatment currently in a phase 1 study. deena beasley / Reuters Amgen AMGN 2.94 %incr...

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment
Nasdaq 3d
Amgen Inc. Profit Rises In Q2

(RTTNews) - Amgen Inc. (AMGN) announced earnings for its second quarter that Increases, from last year The company's bottom line totaled $2.375 billion, or $4....

Amgen Inc. Profit Rises In Q2
Nasdaq 3d
Dow Analyst Moves: AMGN

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Amgen is the #21...

Dow Analyst Moves: AMGN
Nasdaq 3d
See How Amgen Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that Amgen Inc (Symbol: AMGN) is the #17 broker pick, on average, out of the 30 stocks making u...

See How Amgen Ranks Among Analysts' Top Dow 30 Picks
TipRanks 3d
Amgen Extends Obesity Trial, Sharpening Its Long-Term Weight-Loss Bet

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.